Clinical Trial Update: Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/ Recurrent Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating nelmastobart in combination with trifluridine/tipiracil and bevacizumab for metastatic or recurrent colorectal cancer a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Nelmastobart (nelmastobart)
• trifluridine/tipiracil (trifluridine/tipiracil)

Snippet

Sponsor: STCube, Inc. | Conditions: Metastatic Colorectal Cancer (CRC), Recurrent Colorectal Cancer | Phase 1, Phase 2 | Status: RECRUITING